Editorial
doi: 10.1056/NEJMe058304.
Intensive insulin in intensive care
- PMID: 16452564
- PMCID: PMC2287193
- DOI: 10.1056/NEJMe058304
Item in Clipboard
Editorial
Intensive insulin in intensive care
N Engl J Med.
.
No abstract available
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment in
-
Intensive insulin therapy in the medical ICU.N Engl J Med. 2006 May 11;354(19):2069-71; author reply 2069-71. N Engl J Med. 2006. PMID: 16696140 No abstract available.
Comment on
-
Intensive insulin therapy in the medical ICU.N Engl J Med. 2006 Feb 2;354(5):449-61. doi: 10.1056/NEJMoa052521. N Engl J Med. 2006. PMID: 16452557 Clinical Trial.
Similar articles
-
Intensive insulin therapy in the medical ICU.N Engl J Med. 2006 May 11;354(19):2069-71; author reply 2069-71. N Engl J Med. 2006. PMID: 16696140 No abstract available.
-
Intensive insulin therapy in the medical ICU.N Engl J Med. 2006 Feb 2;354(5):449-61. doi: 10.1056/NEJMoa052521. N Engl J Med. 2006. PMID: 16452557 Clinical Trial.
-
Intensive insulin therapy in critically ill patients.N Engl J Med. 2002 May 16;346(20):1586-8; author reply 1586-8. N Engl J Med. 2002. PMID: 12017161 No abstract available.
-
Alterations of blood glucose homeostasis in critically ill children - hyperglycemia.Pediatr Endocrinol Diabetes Metab. 2007;13(1):43-6. Pediatr Endocrinol Diabetes Metab. 2007. PMID: 17493406 Review.
-
Glycemic control and nutritional strategies in the cardiothoracic surgical intensive care unit--2010: state of the art.Semin Thorac Cardiovasc Surg. 2010 Autumn;22(3):230-5. doi: 10.1053/j.semtcvs.2010.10.006. Semin Thorac Cardiovasc Surg. 2010. PMID: 21167457 Review.
Cited by
-
Impact of stress hyperglycemia ratio on mortality in patients with cardiac arrest: insight from American MIMIC-IV database.Front Endocrinol (Lausanne). 2024 May 21;15:1383993. doi: 10.3389/fendo.2024.1383993. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38836227 Free PMC article.
-
Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.Endocrinol Diabetes Metab. 2022 Jan;5(1):e00301. doi: 10.1002/edm2.301. Epub 2021 Sep 29. Endocrinol Diabetes Metab. 2022. PMID: 34585841 Free PMC article.
-
Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus.Res Sq [Preprint]. 2021 Mar 26:rs.3.rs-287308. doi: 10.21203/rs.3.rs-287308/v1. Res Sq. 2021. Update in: Endocrinol Diabetes Metab. 2022 Jan;5(1):e00301. doi: 10.1002/edm2.301 PMID: 33791691 Free PMC article. Updated. Preprint.
-
Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19.Endocr Pract. 2020 Oct;26(10):1166-1172. doi: 10.4158/EP-2020-0466. Endocr Pract. 2020. PMID: 33471718 Free PMC article.
-
Lipopolysaccharide Potentiates Insulin-Driven Hypoglycemic Shock.J Immunol. 2017 Nov 15;199(10):3634-3643. doi: 10.4049/jimmunol.1700820. Epub 2017 Oct 16. J Immunol. 2017. PMID: 29038248 Free PMC article.
References
-
- Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67. - PubMed
-
- Angus DC, Abraham E. Intensive insulin therapy in critical illness. Am J Respir Crit Care Med. 2005;172:1358–9. - PubMed
-
- Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61. - PubMed
-
- Brown RT, Polinsky RJ, Lee GK, Deeter JA. Insulin-induced hypotension and neurogenic orthostatic hypotension. Neurology. 1986;36:1402–6. - PubMed
-
- McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
